Währungen / GSK
GSK: GSK plc American Depositary Shares (Each representing two Ordin
37.55
USD
0.13
(0.35%)
Der Wechselkurs von GSK hat sich für heute um -0.35% verändert. Im Laufe des Tages wurde das Instrument von einem Tief von 37.17 bis zu einem Hoch von 37.78 gehandelt.
Verfolgen Sie die GSK plc American Depositary Shares (Each representing two Ordin-Dynamik. Mit Echtzeit-Kursen können Sie schnell auf Marktveränderungen reagieren. Indem Sie zwischen verschiedenen Zeitrahmen wechseln, können Sie Kurstrends und -dynamik nach Minuten, Stunden, Tagen, Wochen und Monaten verfolgen. Nutzen Sie diese Informationen, um Marktveränderungen vorherzusagen und fundierte Handelsentscheidungen zu treffen.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
GSK News
- Investing Trump demands pharma CEOs lower drug prices within 60 days
- Zacks Company News for Jul 31, 2025
- Investing U.K. stocks lower at close of trade; Investing.com United Kingdom 100 down 0.06%
- Zacks GSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise
- Benzinga Why Is GSK Stock Gaining On Wednesday? - GSK (NYSE:GSK)
- Investing FTSE 100 today: Index falls as HSBC, Rio Tinto, BAE results weigh; Bodycote soars
- Zacks GSK (GSK) Q2 Earnings and Revenues Beat Estimates
- Investing GSK in talks with Trump administration on U.S. drug pricing, CEO says
- Investing GSK lifts 2025 forecast after profit jumps on strong HIV, cancer drug sales
- Investing GSK Q2 2025 presentation: Sales up 6%, EPS jumps 15% as Specialty Medicines lead growth
- Investing Morning Bid: No more sleep this week
- Benzinga GSK, Hengrui Pharma Sign Deal For COPD Therapy, 12 Drugs - GSK (NYSE:GSK)
- Investing GSK announces $500 million collaboration with Hengrui Pharma for drug development
- Investing FTSE 100 today: Index slips, pound below $1.35; U.K. retail sales miss in June
- Benzinga GSK's Blood Cancer Drug Review Extended As FDA Seeks More Data - GSK (NYSE:GSK)
- Zacks Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
- Seeking Alpha Dodge & Cox International Stock Fund Q2 2025 Shareholder Letter
- Investing FDA extends review period for GSK’s Blenrep in multiple myeloma
- Seeking Alpha Dodge & Cox Balanced Fund Q2 2025 Shareholder Letter
- Zacks GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth
- Zacks Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect
- Investing U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.17%
- Zacks FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo
- Zacks These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Tagesspanne
37.17
37.78
Jahresspanne
31.71
44.27
- Vorheriger Schlusskurs
- 37.15
- Eröffnung
- 37.68
- Bid
- 37.55
- Ask
- 37.85
- Tief
- 37.17
- Hoch
- 37.78
- Volumen
- 7.175 K
- Tagesänderung
- -0.35%
- Monatsänderung
- -0.35%
- 6-Monatsänderung
- -1.65%
- Jahresänderung
- -13.97%
03 August, Sonntag